Equity Research, Broker Reports, and media content on BIOCARTIS NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about BIOCARTIS NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on BIOCARTIS NV. We currently have 0 research reports from 0 professional analysts.

Open
10.3
Volume
0.0m
Range
10.2/10.4
Market Cap
459,875,511m
52 Week
6.60/12.5
Date Source Announcement
15Mar17 06:00 GNW Biocartis receives grant for development of a fully automated MSI test
09Mar17 06:00 GNW Biocartis Group NV: Study using Biocartis' liquid biopsy BRAF assay shows new option for retreatment of melanoma patients
02Mar17 06:01 GNW Biocartis Group NV: Biocartis announces 2016 results, 2017 outlook and change in CEO position
02Mar17 06:00 GNW Biocartis Group NV: Important milestone in Biocartis-Merck collaboration with launch of second liquid biopsy assay
23Feb17 06:00 GNW Biocartis Group NV: Biocartis to host webcast for announcement 2016 financial results on 2 March 2017
22Dec16 06:01 GNW Biocartis Group NV: Biocartis and Amgen sign a RAS Biomarker Testing Collaboration in Europe
22Dec16 06:00 GNW Biocartis Group NV: Biocartis submits 510(k) file with US FDA for Idylla(TM) platform
  • Frequency of research reports

     

  • Research reports on

    BIOCARTIS NV

  • Providers covering

    BIOCARTIS NV